• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.氟氯西林导致伏立康唑的血浆浓度不理想。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00915-17. Print 2017 Sep.
2
Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections.CYP2C19、CYP3A4、ABCB1 和 FMO3 基因型对泰国侵袭性真菌感染患者伏立康唑血药浓度的影响。
Pharmacol Res Perspect. 2020 Dec;8(6):e00665. doi: 10.1002/prp2.665.
3
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.在肾功能损害的血液学患者中,用磺丁基醚β-环糊精配制的静脉注射伏立康唑的治疗药物监测与安全性
Mycoses. 2016 Oct;59(10):644-51. doi: 10.1111/myc.12517. Epub 2016 Jun 21.
4
Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.伏立康唑的儿科临床药理学:药代动力学/药效学模型在药物治疗中的作用
Clin Pharmacokinet. 2016 Sep;55(9):1031-43. doi: 10.1007/s40262-016-0379-2.
5
Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.成人侵袭性真菌感染伏立康唑治疗的优化。
Clin Pharmacol Ther. 2018 Nov;104(5):957-965. doi: 10.1002/cpt.1012. Epub 2018 Feb 13.
6
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.伏立康唑的治疗药物监测有助于降低目标谷浓度不达标的患者比例。
Med Mycol. 2016 May;54(4):353-60. doi: 10.1093/mmy/myv099. Epub 2016 Jan 6.
7
Fulminant mulch pneumonitis in a previously healthy child.一名既往健康儿童发生暴发性堆肥肺炎。
Arch Pediatr. 2018 Nov;25(8):495-496. doi: 10.1016/j.arcped.2018.09.003. Epub 2018 Oct 16.
8
Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report.泊沙康唑与氟氯西林在肺移植患者体内的相互作用:泊沙康唑血药浓度降低,可能导致侵袭性曲霉菌病治疗不足:病例报告。
BMC Pulm Med. 2022 Mar 27;22(1):110. doi: 10.1186/s12890-022-01904-4.
9
Broad-spectrum azoles and flucloxacillin: a dangerous match.广谱唑类药物和氟氯西林:危险组合。
Eur J Clin Microbiol Infect Dis. 2022 Jan;41(1):153-154. doi: 10.1007/s10096-021-04333-z. Epub 2021 Sep 7.
10
Serum Aspergillus fumigatus-specific IgG antibody decreases after antifungal treatment in chronic pulmonary aspergillosis patients.在慢性肺曲霉病患者中,抗真菌治疗后血清烟曲霉特异性IgG抗体水平下降。
Clin Respir J. 2018 Apr;12(4):1772-1774. doi: 10.1111/crj.12702. Epub 2017 Sep 14.

引用本文的文献

1
Metamizole induces voriconazole metabolism and results in subtherapeutic voriconazole concentrations.安乃近可诱导伏立康唑代谢,导致伏立康唑血药浓度低于治疗水平。
Br J Clin Pharmacol. 2025 Sep;91(9):2598-2604. doi: 10.1002/bcp.70079. Epub 2025 Apr 27.
2
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and Flucloxacillin.用于解释伏立康唑与氟氯西林药物相互作用患者的全身生理药代动力学模型。
Eur J Drug Metab Pharmacokinet. 2024 Nov;49(6):689-699. doi: 10.1007/s13318-024-00916-1. Epub 2024 Sep 14.
3
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users.双氯西林是肠道 P 糖蛋白的诱导剂,但无论是双氯西林还是氟氯西林,都不会增加直接口服抗凝剂使用者中风/全身性栓塞的风险。
Br J Clin Pharmacol. 2024 Dec;90(12):3252-3262. doi: 10.1111/bcp.16190. Epub 2024 Aug 19.
4
The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review.抗生素药代动力学驱动的药物相互作用问题:一篇叙述性综述。
Antibiotics (Basel). 2022 Oct 13;11(10):1410. doi: 10.3390/antibiotics11101410.
5
Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.提高对克林霉素药理学和药代动力学的认识以适应实际应用的方法。
Antibiotics (Basel). 2022 May 21;11(5):701. doi: 10.3390/antibiotics11050701.
6
Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report.泊沙康唑与氟氯西林在肺移植患者体内的相互作用:泊沙康唑血药浓度降低,可能导致侵袭性曲霉菌病治疗不足:病例报告。
BMC Pulm Med. 2022 Mar 27;22(1):110. doi: 10.1186/s12890-022-01904-4.
7
Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid.伏立康唑与氟氯西林联合治疗:应避免的组合。
Antibiotics (Basel). 2021 Sep 15;10(9):1112. doi: 10.3390/antibiotics10091112.
8
Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study.氟氯西林降低他克莫司血药谷浓度:单中心回顾性队列研究。
Eur J Clin Pharmacol. 2020 Dec;76(12):1667-1673. doi: 10.1007/s00228-020-02968-z. Epub 2020 Jul 25.
9
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.重症监护病房患者流感相关肺曲霉病综述及病例定义建议:专家意见
Intensive Care Med. 2020 Aug;46(8):1524-1535. doi: 10.1007/s00134-020-06091-6. Epub 2020 Jun 22.
10
Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro.紫杉醇、伊马替尼和5-氟尿嘧啶在体外增加氟氯西林的游离分数。
Antibiotics (Basel). 2020 Jun 8;9(6):309. doi: 10.3390/antibiotics9060309.

本文引用的文献

1
Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection.伏立康唑与氟氯西林在播散性尖端赛多孢菌感染治疗过程中的相互作用。
J Antimicrob Chemother. 2015 Jul;70(7):2171-3. doi: 10.1093/jac/dkv069. Epub 2015 Mar 15.
2
Steady-state pharmacokinetics and metabolism of voriconazole in patients.患者伏立康唑的稳态药代动力学和代谢。
J Antimicrob Chemother. 2013 Nov;68(11):2592-9. doi: 10.1093/jac/dkt229. Epub 2013 Jun 13.
3
In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.体外肝脏代谢解释了儿童比成人清除伏立康唑的清除率更高:CYP2C19 和黄素单加氧酶 3 的作用。
Drug Metab Dispos. 2010 Jan;38(1):25-31. doi: 10.1124/dmd.109.029769.
4
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.唑类抗真菌药物与其他共同给药药物的药代动力学相互作用的临床相关性。
Clin Infect Dis. 2009 May 15;48(10):1441-58. doi: 10.1086/598327.
5
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.细胞色素P450 2C19基因分型是导致伏立康唑药代动力学高度可变的主要因素。
J Clin Pharmacol. 2009 Feb;49(2):196-204. doi: 10.1177/0091270008327537. Epub 2008 Nov 25.
6
Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes.含黄素单加氧酶在人肝微粒体对伏立康唑氧化代谢中的作用。
Drug Metab Dispos. 2008 Jun;36(6):1119-25. doi: 10.1124/dmd.107.019646. Epub 2008 Mar 24.
7
Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.CYP3A4和CYP2C19在新型抗真菌药物伏立康唑在人肝微粒体中形成甲基羟基化和N-氧化代谢产物过程中的作用。
Biochem Pharmacol. 2007 Jun 15;73(12):2020-6. doi: 10.1016/j.bcp.2007.03.012. Epub 2007 Mar 19.
8
Pharmacokinetic interactions with rifampicin : clinical relevance.与利福平的药代动力学相互作用:临床相关性。
Clin Pharmacokinet. 2003;42(9):819-50. doi: 10.2165/00003088-200342090-00003.
9
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human.伏立康唑在小鼠、大鼠、兔、豚鼠、狗和人类体内的处置情况。
Drug Metab Dispos. 2003 Jun;31(6):731-41. doi: 10.1124/dmd.31.6.731.
10
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.参与伏立康唑N-氧化的细胞色素P450酶的鉴定。
Drug Metab Dispos. 2003 May;31(5):540-7. doi: 10.1124/dmd.31.5.540.

氟氯西林导致伏立康唑的血浆浓度不理想。

Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.

机构信息

Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands

Center of Expertise in Mycology Radboudumc/CWZ and Radboud Institute of Health Science, Nijmegen, The Netherlands.

出版信息

Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00915-17. Print 2017 Sep.

DOI:10.1128/AAC.00915-17
PMID:28717040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5571297/
Abstract

Combining voriconazole and flucloxacillin is indicated in patient cohorts experiencing both invasive aspergillosis and Gram-positive infections (e.g., patients with chronic granulomatous disease or postinfluenza pulmonary aspergillosis). We report a highly relevant interaction between voriconazole and flucloxacillin, resulting in subtherapeutic plasma voriconazole concentrations in more than 50% of patients, that poses a severe threat if not managed properly.

摘要

联合伏立康唑和氟氯西林适用于同时患有侵袭性曲霉病和革兰阳性感染的患者群体(例如,患有慢性肉芽肿病或流感后肺部曲霉病的患者)。我们报告了伏立康唑和氟氯西林之间存在高度相关的相互作用,导致超过 50%的患者的伏立康唑血浆浓度低于治疗范围,如果不进行适当管理,这将构成严重威胁。